Beijing released specific rules on experiments relating to COVID-19 and banned any activities that fall beyond regulatory approval, the capital's health authority said in a newly released notice, in a move to further strengthen COVID-19 laboratory biosafety.
Related Keywords
China , Beijing , , Municipal Health Commission , National Health Commission , China National Pharmaceutical Group Sinopharm , Xinhua , China National Pharmaceutical Group , Beijing Municipal Health Commission , Beijing Municipal Health , Laboratory , Health , Strengthen , Commission ,
comparemela.com © 2020. All Rights Reserved.